FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:2653-2655 December 27, 2007 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

In April 1984, when the human immunodeficiency virus (HIV) and AIDS were just beginning to be understood, a senior official in the Department of Health and Human Services stated at a press conference that there would be a marketable vaccine within "a minimum of two years, probably more like three years."¹ This prediction has haunted the search for an AIDS vaccine, whose most recent setback was the announcement that a promising vaccine candidate, Merck's V520, was not effective and may actually have increased some subjects' risk of acquiring HIV. Unfortunately, about a quarter-century after the discovery of HIV, there is . . . [Full Text of this Article]

Source Information

Dr. Steinbrook (rsteinbrook@attglobal.net) is a national correspondent for the Journal.

This article has been cited by other articles:

• Matthews, P. C., Prendergast, A., Leslie, A., Crawford, H., Payne, R., Rousseau, C., Rolland, M., Honeyborne, I., Carlson, J., Kadie, C., Brander, C., Bishop, K., Mlotshwa, N., Mullins, J. I., Coovadia, H., Ndung'u, T., Walker, B. D., Heckerman, D., Goulder, P. J. R. (2008). Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point. J. Virol. 82: 8548-8559 [Abstract] [Full Text]  
• Vaine, M., Wang, S., Crooks, E. T., Jiang, P., Montefiori, D. C., Binley, J., Lu, S. (2008). Improved Induction of Antibodies against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 gp120 DNA Prime-Protein Boost Vaccination Compared to gp120 Protein-Only Vaccination. J. Virol. 82: 7369-7378 [Abstract] [Full Text]  
• Van Damme, L., Govinden, R., Mirembe, F. M., Guedou, F., Solomon, S., Becker, M. L., Pradeep, B.S., Krishnan, A.K., Alary, M., Pande, B., Ramjee, G., Deese, J., Crucitti, T., Taylor, D., the CS Study Group, (2008). Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission. NEJM 359: 463-472 [Abstract] [Full Text]  
• Fauci, A. S., Johnston, M. I., Dieffenbach, C. W., Burton, D. R., Hammer, S. M., Hoxie, J. A., Martin, M., Overbaugh, J., Watkins, D. I., Mahmoud, A., Greene, W. C. (2008). HIV Vaccine Research: The Way Forward. Science 321: 530-532 [Abstract] [Full Text]  
• Walker, B. D., Burton, D. R. (2008). Toward an AIDS Vaccine. Science 320: 760-764 [Abstract] [Full Text]  
• Yang, K., Whalen, B. J., Tirabassi, R. S., Selin, L. K., Levchenko, T. S., Torchilin, V. P., Kislauskis, E. H., Guberski, D. L. (2008). A DNA Vaccine Prime Followed by a Liposome-Encapsulated Protein Boost Confers Enhanced Mucosal Immune Responses and Protection. J. Immunol. 180: 6159-6167 [Abstract] [Full Text]